Effectiveness of radiotherapy for patients with indolent non-Hodgkin's lymphoma

被引:0
|
作者
Hadi, I. [1 ]
Schummer, A. [1 ]
Eze, C. [1 ]
Dreyling, M. [2 ]
Belka, C. [1 ]
Li, M. [1 ]
机构
[1] Univ Hosp LMU, Dept Radiat Oncol, Munich, Germany
[2] Univ Hosp LMU, Dept Oncol, Munich, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-0913
引用
收藏
页码:S487 / S488
页数:2
相关论文
共 50 条
  • [41] Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma
    Friedberg, Jonathan W.
    HAEMATOLOGICA, 2008, 93 (03) : 336 - 338
  • [42] Rituxan delays disease progression in indolent non-Hodgkin's lymphoma
    不详
    ONCOLOGY-NEW YORK, 2002, 16 (11): : 1472 - 1472
  • [43] A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma
    Brandt, L
    Kimby, E
    Nygren, P
    Glimelius, B
    ACTA ONCOLOGICA, 2001, 40 (2-3) : 213 - 223
  • [44] Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma
    LaCasce, Ann S.
    Freedman, Arnold S.
    SEMINARS IN HEMATOLOGY, 2008, 45 (02) : 85 - 89
  • [45] Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma
    Saven, A
    Lee, T
    Kosty, M
    Piro, L
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) : 2139 - 2144
  • [46] Optimizing the clinical benefit of rituximab - in indolent non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2004, 5 (03): : 149 - 151
  • [47] Palliative radiotherapy in eyelid non-Hodgkin's lymphoma
    Galeazzi, G
    Di Russo, A
    Boffi, R
    De Conno, F
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4601 - 4602
  • [48] Indolent non-Hodgkin lymphoma primarily involving the hard palate: outcome following radiotherapy
    Milgrom, Sarah A.
    Yahalom, Joachim
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1208 - 1211
  • [49] Considerations with newer regimens for indolent non-Hodgkin lymphoma
    Rummel, Mathias
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 : S128 - S136
  • [50] Radiotherapy indications in non-Hodgkin lymphoma
    Quero, L.
    Hennequin, C.
    Brice, P.
    CANCER RADIOTHERAPIE, 2009, 13 (6-7): : 471 - 478